Acetoacetyl CoA is the precursor of the synthesis of β-hydroxy-β-methylglutarate monoacyl CoA (HMG-CoA) through the mevalonate pathway, which is controlled by HMG-CoA synthase and is essential for cholesterol synthesis. It also plays a role in the biosynthesis of ketone bodies in the liver, where the process begins with two Acetyl-CoA molecules that condense to acetoacetyl CoA under the action of acetoacetyl-CoA thiolase to. In addition, phosphotransferase (PTB) and poly-3-hydroxybutyrate (PHB) can be biosynthesized from acetoacetyl CoA, and PHB has a high application prospect.
Fig.1 Acetoacetyl CoA in the biosynthesis of ketone bodies. (CD BioGlyco)
Enzyme-catalyzed biosynthesis strategy is adopted. The gene encoding acetoacetyl-CoA synthetase from the streptomyces strain is recombined and overexpressed into Escherichia coli, and the target product is prepared by fermentation followed by purification.
CD BioGlyco provides acetoacetyl CoA in solid form. Before the application, the aqueous solution can be prepared by solving acetoacetyl CoA solid directly into phosphate-buffered saline (PSB). It is recommended to use the solution immediately, and the storage time should not exceed one day.
CD BioGlyco has a large team of scientists and state-of-the-art Platforms. It is our mission to provide you with custom solutions and quality services in the development and production of biotechnology and therapies for diseases. If you are interested in our Custom Sugar-nucleotides Synthesis service, please feel free to contact us now.
About Us
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.